FREQUENT, UNUSUALLY SEVERE, LONG LASTING, LOCAL AND SYSTEMIC PNEUMOCOCCAL VACCINE REACTIONS IN PATIENTS WITH CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES (CAPS): RESULTS OF A PROSPECTIVE REGISTRY BASED STUDY

被引：0
|
作者：
Jaeger, V. K. [1 ]
Hoffmann, H. M. [2 ,3 ]
van der Poll, T. [4 ]
Tilson, H. [5 ]
Seibert, J. [6 ]
Speziale, A. [6 ]
Junge, G. [6 ]
Franke, K. [7 ]
Vritzali, E. [6 ]
Hawkins, P. N. [8 ]
Kuemmerle-Deschner, J. [9 ]
Walker, U. A. [1 ]
机构：
[1] Univ Hosp Basel, Basel, Switzerland
[2] Univ Calif San Diego, San Diego, CA 92103 USA
[3] Rady Childrens Hosp, San Diego, CA USA
[4] Univ Amsterdam, Amsterdam, Netherlands
[5] Univ N Carolina, Chapel Hill, NC USA
[6] Novartis Pharma AG, Basel, Switzerland
[7] Real World Insights, QuintilesIMS, Durham, NC USA
[8] UCL, London, England
[9] Univ Hosp Tubingen, Tubingen, Germany
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷
关键词：
D O I：
10.1136/annrheumdis-2017-eular.1513
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0585
引用
收藏
页码：710 / 711
页数：2
相关论文
共 25 条
  • [1] Safety of vaccinations in patients with cryopyrin-associated periodic syndromes: a prospective registry based study
    Jaeger, Veronika K.
    Hoffman, Hal M.
    van der Poll, Tom
    Tilson, Hugh
    Seibert, Julia
    Speziale, Antonio
    Junge, Guido
    Franke, Kristina
    Vritzali, Eleni
    Hawkins, Philip N.
    Kuemmerle-Deschner, Jasmin
    Walker, Ulrich A.
    [J]. RHEUMATOLOGY, 2017, 56 (09) : 1484 - 1491
  • [2] Microarray-based gene expression studies of systemic inflammation in patients with cryopyrin-associated periodic syndromes (CAPS)
    Balow, Jr J.
    Sun, H.
    Godbach-Mansky, R.
    Kastner, D.
    Aksentijevich, I.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (02) : 178 - 178
  • [3] Long-term safety profile of anakinra in patients with severe cryopyrin-associated periodic syndromes
    Kullenberg, Torbjorn
    Lofqvist, Malin
    Leinonen, Mika
    Goldbach-Mansky, Raphaela
    Olivecrona, Hans
    [J]. RHEUMATOLOGY, 2016, 55 (08) : 1499 - 1506
  • [4] Long term management of patients with cryopyrin-associated periodic syndromes (CAPS): focus on rilonacept (IL- 1 Trap)
    Church, Leigh D.
    Savic, Sinisa
    McDermott, Michael F.
    [J]. BIOLOGICS-TARGETS & THERAPY, 2008, 2 (04): : 733 - 742
  • [5] Long-term safety and efficacy of Canakinumab in cryopyrin-associated periodic syndrome (CAPS) patients: Results from beta-confident registry
    Kuemmerle-Deschner J.
    Hoffman H.
    Hawkins P.N.
    van der Poll T.
    Walker U.A.
    Speziale A.
    Tilson H.H.
    [J]. Pediatric Rheumatology, 13 (Suppl 1)
  • [6] Dosing patterns of canakinumab in patients with Cryopyrin-Associated Periodic Syndromes (CAPS): A comparative analysis of a study in Western versus Japanese patients
    B Bader-Meunier
    P Hachulla
    J Kuemmerle-Deschner
    M Gattorno
    N Patel
    R Preiss
    K Lheritier
    T Imagawa
    R Nishikomori
    H Takada
    T Heike
    T Hara
    S Yokota
    [J]. Pediatric Rheumatology, 9 (Suppl 1)
  • [7] SAFETY PROFILE OF THE IL-1 RECEPTOR ANTAGONIST KINERET® (ANAKINRA) IN A LONG-TERM OUTCOME STUDY IN PATIENTS WITH SEVERE CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES (CAPS)
    Kullenberg, T.
    Lofqvist, M.
    Olivecrona, H.
    Plass, N.
    Kost, B.
    Sibley, C.
    Goldbach-Mansky, R.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 745 - 746
  • [8] SAFETY RESULTS FROM THE B-CONFIDENT REGISTRY IN CANAKINUMAB-TREATED PATIENTS WITH CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME (CAPS)
    Kuemmerle-Deschner, J. B.
    Tilson, H.
    Hawkins, P. N.
    van der Poll, T.
    Walker, U. A.
    Rauer, B.
    Nebesky, J. M.
    Kim, D.
    Davis, N.
    Hoffman, H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 321 - 321
  • [9] Dose Adjustment of Anakinra (Kineret®) Based on Clinical Response in Patients with Severe Cryopyrin-Associated Periodic Syndromes
    Hallen, Bengt
    Kullenberg, Torbjorn
    Leinonen, Mika
    Wiken, Margareta
    Goldbach-Mansky, Raphaela
    Olivecrona, Hans
    [J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [10] LONG-TERM SAFETY AND EFFECTIVENESS OF CANAKINUMAB IN CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES (CAPS)-30-MONTH DATA FROM THE RELIANCE REGISTRY
    Kuemmerle-Deschner, J. B.
    Kortus-Goetze, B.
    Oommen, P.
    Janda, A.
    Rech, J.
    Kallinich, T.
    Weller-Heinemann, F.
    Horneff, G.
    Foeldvari, I.
    Schuetz, C.
    Borte, M.
    Braner, A.
    Weber-Arden, J.
    Blank, N.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 50 - 51
123